Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine.
about
IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestineA multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse.Small intestinal submucosa seeded with intestinal smooth muscle cells in a rodent jejunal interposition modelTeduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblastsThe effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine.Glucose sensing and signalling; regulation of intestinal glucose transport.Are synthetic scaffolds suitable for the development of clinical tissue-engineered tubular organs?Glucagon-like peptide 2 increases efficacy of distraction enterogenesis.Effect of glucagon-like peptide-2 (GLP-2) on diurnal SGLT1 expression.Tissue Engineering Functional Gastrointestinal Regions: The Importance of Stem and Progenitor Cells.Human tissue-engineered colon forms from postnatal progenitor cells: an in vivo murine model.Role of nutrient-sensing taste 1 receptor (T1R) family members in gastrointestinal chemosensing.Tissue-engineered small intestine improves recovery after massive small bowel resection.Composite Scaffolds Based on Intestinal Extracellular Matrices and Oxidized Polyvinyl Alcohol: A Preliminary Study for a New Regenerative Approach in Short Bowel Syndrome.Glucagon-Like Peptide-2 and the Enteric Nervous System Are Components of Cell-Cell Communication Pathway Regulating Intestinal Na/Glucose Co-transport
P2860
Q34982361-009B651D-D4E3-47D3-9FA2-39E9E5AD0390Q35055508-657C7EC8-291D-425A-92F2-3169C43879BDQ35375894-82FF8A8B-A9C9-4B64-A5BF-9E1A4EDF7D41Q35597698-67E45459-6C47-439C-87E1-22853F49878CQ36063090-A9BFDAE1-9E32-437A-9E81-4872E31FFC5CQ37199730-46368116-F1FF-430B-A24A-B1DF51B0A4AAQ37859449-282ADD64-CB42-4A41-BA81-C02A5C288C74Q38124847-60C5C670-9BD1-4C2C-8975-28510D8A20BDQ42011022-040BE356-D565-4B36-9555-C1644703D3FFQ45208837-2986201E-F564-4597-9E3A-D6D7CC6D50A9Q46123678-6FB5732B-1F94-4B2E-A205-C457CD3461C8Q46140184-4F6D4E26-30E2-47A2-85A0-BC3780790927Q46952441-91161A41-CA38-464B-828D-28CD0D657609Q50789084-FAD14BB9-E9C0-40D3-BC43-2BF6B84BD803Q55476361-58414AD8-9923-4735-B742-F2078E230F01Q58707940-F50EB527-50DB-48A9-AA35-97BAC75C81F0
P2860
Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@en
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@nl
type
label
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@en
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@nl
prefLabel
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@en
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@nl
P2093
P2860
P356
P1476
Effect of GLP-2 on mucosal mor ...... issue-engineered neointestine.
@en
P2093
Alexander Perez
Anthony Ramsanahie
David B Rhoads
Edward E Whang
James Gardner-Thorpe
Jennifer Ogilvie
Joseph P Vacanti
Mark S Duxbury
Stanley W Ashley
Tracy C Grikscheit
P2860
P304
P356
10.1152/AJPGI.00374.2002
P577
2003-08-14T00:00:00Z